SPONSOR
Centre Antoine Lacassagne
Total Trials
2
Recruiting
2
Phases
Phase 2
Centre Antoine Lacassagne is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Carcinoma, Non-Small-Cell Lung (NSCLC), Localized Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centre Antoine Lacassagne
How many clinical trials has Centre Antoine Lacassagne sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Centre Antoine Lacassagne, of which 2 are actively recruiting participants. These trials cover conditions including Carcinoma, Non-Small-Cell Lung (NSCLC), Localized Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centre Antoine Lacassagne research focus on?
Centre Antoine Lacassagne clinical trials span Carcinoma, Non-Small-Cell Lung (NSCLC), Localized Breast Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Centre Antoine Lacassagne clinical trial?
To participate in a Centre Antoine Lacassagne trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre Antoine Lacassagne trials with current recruitment status updated daily.
Clinical Trials by Centre Antoine Lacassagne
NCT06833229
Recruiting
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
Carcinoma, Non-Small-Cell Lung (NSCLC)
NCT04680715 Phase 2
Recruiting
Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
Localized Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology